Reta usually means retatrutide, an experimental weight loss drug. Learn what is reta for fat loss, how it works, trial results, and key safety facts.
Reta is a nickname for retatrutide, an experimental once-weekly injectable drug that researchers are studying for obesity and type 2 diabetes. Retatrutide is a triple hormone receptor agonist that targets GLP-1, GIP, and glucagon at the same time. Retatrutide is not FDA-approved for fat loss or any other use in the United States, so it is not legally available by prescription.
If you see the word 'reta' in a diet group or a search box, it almost always means retatrutide. It is not a vitamin, a fat-burning supplement, or a diet plan.
Reta Meaning: What the Nickname Refers To
People shorten retatrutide to 'reta' because the full name is long and hard to spell. The nickname spread through Reddit, TikTok, and fitness forums as more people searched for 'reta WebMD' and 'reta meaning diet.'
In diet and weight loss conversations, 'reta' means the investigational drug retatrutide. It does not mean retinol, it is not the same as the acne treatment tretinoin, and it is not a brand name for any approved medication.
A WebMD-style drug lookup will not show reta as an approved weight loss drug because the FDA has not approved it. Some drug reference pages describe it as an investigational agent, which is accurate as of 2025.
How Retatrutide Works for Fat Loss
Retatrutide is a single molecule that activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP are gut hormones that help regulate appetite, insulin release, and stomach emptying. Glucagon is better known for raising blood sugar, but it also increases energy expenditure and fat burning.
By hitting all three pathways, retatrutide may reduce hunger, slow digestion, and raise calorie burn at the same time. That combination is why researchers hope it can produce more weight loss than single-agonist drugs like semaglutide or dual-agonist drugs like tirzepatide.
That hope is still a hypothesis. No head-to-head trial has compared retatrutide directly with tirzepatide or semaglutide, so all comparisons come from separate studies with different designs.
How Much Weight Loss Has Reta Produced in Trials?
The main human data come from a Phase 2 trial published in the New England Journal of Medicine in 2023. The trial enrolled 338 adults with obesity or overweight plus at least one weight-related condition. Participants received weekly injections of retatrutide or placebo for 48 weeks.
- 12 mg dose: average weight loss of 24.2%
- 8 mg dose: average weight loss of 22.8%
- 4 mg dose: average weight loss of 17.5%
- Placebo: average weight loss of 2.1%
Weight loss was dose-dependent, meaning higher doses produced more loss on average. The Phase 3 TRIUMPH program is now testing retatrutide in larger and longer trials, and results are expected over the next few years.
For context, 24.2% weight loss is larger than the average loss seen with any FDA-approved weight loss medication in its own pivotal trial. Cross-trial comparisons should be read with caution, but the number is the main reason reta gets so much attention.
Reta vs. Tirzepatide and Semaglutide
Many people searching for is reta or tirz better for weight loss are really asking whether retatrutide beats tirzepatide. No direct comparison exists yet, so the table below shows results from separate trials.
| Drug | Receptors targeted | FDA status | Average weight loss in key trial |
|---|---|---|---|
| Retatrutide (reta) | GLP-1, GIP, glucagon | Investigational (Phase 3) | 24.2% at 48 weeks (12 mg, Phase 2) |
| Tirzepatide (Zepbound) | GLP-1, GIP | Approved for weight loss | 20.9% at 72 weeks (15 mg, SURMOUNT-1) |
| Semaglutide (Wegovy) | GLP-1 | Approved for weight loss | 14.9% at 68 weeks (2.4 mg, STEP-1) |
Many people also ask what is the best injection for weight loss, and the honest answer depends on approval status, insurance coverage, side effects, and personal health history. Tirzepatide and semaglutide are available by prescription today; retatrutide is not.
Safety, Side Effects, and Legal Status of Reta
In the Phase 2 trial, the most common side effects were nausea, diarrhea, vomiting, and constipation. Most were mild to moderate and often improved after the first few weeks. Injection site reactions also occurred.
More serious risks seen with GLP-1-based drugs include gallbladder disease, pancreatitis, kidney injury, and delayed stomach emptying. These drugs are not recommended during pregnancy, and they carry a boxed warning about thyroid C-cell tumors based on animal data.
Retatrutide should only be used inside a supervised clinical trial. Products sold online as 'reta' or 'retatrutide research chemical' are not approved for human use, and they may be impure, mislabeled, or contaminated. The FDA has warned about compounded and research-grade GLP-1 products sold outside the legal supply chain.
Alternatives and What to Do If You Are Considering Reta
If you are exploring fat loss options, approved prescription medications include semaglutide (Wegovy), tirzepatide (Zepbound), liraglutide (Saxenda), phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), and orlistat. Lifestyle habits — nutrition, sleep, and physical activity — remain the foundation of any weight loss plan.
Other compounds come up in the same conversations. For example, people ask what is tesa for weight loss; tesamorelin is FDA-approved for HIV-related belly fat, not general weight loss. Some ask what is l'carnitine good for; carnitine plays a role in energy metabolism, but supplement evidence for fat loss is modest. Others ask what is kpv peptide used for; KPV is studied for inflammation, not weight loss.
If you want to try retatrutide, ask your doctor whether any clinical trials are enrolling near you. Do not buy reta from an online vendor, and do not use it without medical supervision. A healthcare professional can help you weigh the risks and benefits of approved options first.
Frequently Asked Questions
Is reta FDA-approved for weight loss?
No. Retatrutide is an investigational drug, and the FDA has not approved it for weight loss or any other use. It is only available to participants in clinical trials. Products sold online as reta are not legal prescription medicines.
How much weight can reta help you lose?
In a Phase 2 trial, adults with obesity who took 12 mg of retatrutide weekly lost an average of 24.2% of their body weight over 48 weeks. The 8 mg and 4 mg doses produced average losses of 22.8% and 17.5%. Individual results vary, and Phase 3 results are not yet available.
Is reta better than tirzepatide for weight loss?
There is no head-to-head trial comparing retatrutide with tirzepatide, so no one can say for sure. Cross-trial comparisons suggest retatrutide may produce slightly more weight loss, but different study designs make that comparison unreliable. Tirzepatide is FDA-approved for weight loss; retatrutide is not.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.